{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,19]],"date-time":"2026-02-19T09:36:19Z","timestamp":1771493779597,"version":"3.50.1"},"reference-count":13,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2007,8,22]],"date-time":"2007-08-22T00:00:00Z","timestamp":1187740800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clin Rheumatol"],"published-print":{"date-parts":[[2008,2]]},"DOI":"10.1007\/s10067-007-0712-0","type":"journal-article","created":{"date-parts":[[2007,8,21]],"date-time":"2007-08-21T10:46:59Z","timestamp":1187693219000},"page":"261-264","source":"Crossref","is-referenced-by-count":27,"title":["C-ANCA positive systemic vasculitis in a patient with rheumatoid arthritis treated with infliximab"],"prefix":"10.1007","volume":"27","author":[{"given":"Dayavathi","family":"Ashok","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shirish","family":"Dubey","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ian","family":"Tomlinson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2007,8,22]]},"reference":[{"key":"712_CR1","first-page":"102287","volume":"30","author":"SJ Jarrett","year":"2003","unstructured":"Jarrett SJ, Cunnane G, Conaghan PG, Bingham SJ, Buch MH, Quinn MA, Emery P (2003) Anti-tumour necrosis factor-\u03b1 therapy induced vasculitis. J Rheumatol 30:102287\u2013102292","journal-title":"J Rheumatol"},{"key":"712_CR2","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1136\/ard.2004.024182","volume":"64","author":"C Eriksson","year":"2005","unstructured":"Eriksson C, Engstrand S, Sundqvist K-G, Rantapaa-Dahlqvist S (2005) Autoantibody formation in patients with rheumatoid arthritis treated with anti-TNF\u03b1. Ann Rheum Dis 64:403\u2013407","journal-title":"Ann Rheum Dis"},{"key":"712_CR3","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1093\/rheumatology\/40.2.178","volume":"40","author":"U Sch\u00f6nermarck","year":"2001","unstructured":"Sch\u00f6nermarck U, Lamprecht P, Csernok E, Gross WL (2001) Prevalence and spectrum of rheumatic diseases associated with proteinase 3-antineutrophil cytoplasmic antibodies (ANCA) and myeloperoxidase-ANCA. Rheumatology 40:178\u2013184","journal-title":"Rheumatology"},{"key":"712_CR4","doi-asserted-by":"crossref","first-page":"866","DOI":"10.7326\/0003-4819-126-11-199706010-00003","volume":"126","author":"PA Merkel","year":"1997","unstructured":"Merkel PA, Polisson RP, Chang Y, Skates SJ, Niles JL (1997) Prevalence of antineutrophil cytoplasmic antibodies in a large inception cohort of patients with connective tissue disease. Ann Intern Med 126:866\u2013873","journal-title":"Ann Intern Med"},{"issue":"1","key":"712_CR5","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1681\/ASN.2005060616","volume":"17","author":"MA Little","year":"2006","unstructured":"Little MA, Bhangal G, Smyth CL, Nakata MT, Cook HT, Noursharg S, Pusey CD (2006) Therapeutic effect of anti-TNF alpha antibodies in an experimental model of anti-neutrophil cytoplasm associated systemic vasculitis. J Am Soc Nephrol 17(1):160\u2013169","journal-title":"J Am Soc Nephrol"},{"key":"712_CR6","doi-asserted-by":"crossref","first-page":"1718","DOI":"10.1161\/01.CIR.0000124720.18538.DD","volume":"109","author":"AD Booth","year":"2004","unstructured":"Booth AD, Jayne DTW, Kharbanda RK, McEniery CM, Mackenzie IS, Brown J, Wilkinson IB (2004) Infliximab improves endothelial dysfunction in systemic vasculitis: a model of vascular inflammation. Circulation 109:1718\u20131723","journal-title":"Circulation"},{"key":"712_CR7","first-page":"2557","volume":"30","author":"M Louis","year":"2003","unstructured":"Louis M, Rauch J, Armstrong M, Fitzcharles MN (2003) Induction of autoantibodies during prolonged treatment with infliximab. J Rheumatol 30:2557\u20132562","journal-title":"J Rheumatol"},{"key":"712_CR8","first-page":"9","volume":"30","author":"E Douglas","year":"2003","unstructured":"Douglas E, Bird K, Flume P, Silver R, Bolster M (2003) Wegener\u2019s granulomatosis in patients with rheumatoid arthritis. J Rheumatol 30:9","journal-title":"J Rheumatol"},{"key":"712_CR9","doi-asserted-by":"crossref","first-page":"1400","DOI":"10.1093\/ndt\/gfh832","volume":"20","author":"MB Stokes","year":"2005","unstructured":"Stokes MB, Foster K, Markowitz GS, Ebrahimi F, Hines W, Kaufman D, Moore B, Wolde D, D\u2019Agati VD (2005) Development of glomerulonephritis during anti-TNF -therapy for rheumatoid arthritis. Nephrol Dial Transplant 20:1400\u20131406","journal-title":"Nephrol Dial Transplant"},{"key":"712_CR10","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1093\/rheumatology\/34.11.1090","volume":"34","author":"D D\u2019Cruz","year":"1995","unstructured":"D\u2019Cruz D, Chesser AMS, Lightowler C, Comer M, Hurst J, Baker LRI, Raine AEG (1995) Antineutrophil cytoplasmic antibody-positive crescentic glomerulonephritis associated with anti-thyroid drug treatment. Br J Rheum 34:1090\u20131091","journal-title":"Br J Rheum"},{"key":"712_CR11","unstructured":"D\u2019Agati VD (1998) Renal disease in systemic lupus erythematosus mixed connective tissue disease, Sjogrens\u2019s syndrome, and rheumatoid arthritis. In: Jennette JC, Oslen JL, Schwartz MM et al (eds) Heptinstall\u2019s pathology of the kidney, vol 1. Lippincott-Raven, PA, pp 541\u2013624"},{"issue":"2","key":"712_CR12","first-page":"131","volume":"110","author":"CM Gaffey","year":"1986","unstructured":"Gaffey CM, Chun B, Harvey JC, Manz HJ (1986) Phenytoin-induced systemic granulomatous vasculitis. Arch Pathol Lab Med 110(2):131\u2013135 (Feb)","journal-title":"Arch Pathol Lab Med"},{"key":"712_CR13","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1136\/ard.61.7.667","volume":"61","author":"R Cuchacovich","year":"2002","unstructured":"Cuchacovich R, Espinoza LR (2002) Soluble TNF receptor treatment does not affect raised TGF beta levels in RA. Ann Rheum Dis 61:667","journal-title":"Ann Rheum Dis"}],"container-title":["Clinical Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-007-0712-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10067-007-0712-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-007-0712-0","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,29]],"date-time":"2019-05-29T08:51:09Z","timestamp":1559119869000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10067-007-0712-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,8,22]]},"references-count":13,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2008,2]]}},"alternative-id":["712"],"URL":"https:\/\/doi.org\/10.1007\/s10067-007-0712-0","relation":{},"ISSN":["0770-3198","1434-9949"],"issn-type":[{"value":"0770-3198","type":"print"},{"value":"1434-9949","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007,8,22]]}}}